- Previous Close
3,483.00 - Open
3,472.00 - Bid 3,440.00 x --
- Ask 3,442.00 x --
- Day's Range
3,429.00 - 3,500.01 - 52 Week Range
3,429.00 - 5,154.00 - Volume
326,114 - Avg. Volume
441,352 - Market Cap (intraday)
4.867B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
29.68 - EPS (TTM)
1.16 - Earnings Date Feb 25, 2025
- Forward Dividend & Yield 1.09 (3.13%)
- Ex-Dividend Date Sep 5, 2024
- 1y Target Est
45.36
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations. In addition, the company offers crop protection and seed enhancement related solutions. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
www.croda.com5,852
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CRDA.L
View MorePerformance Overview: CRDA.L
Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRDA.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRDA.L
View MoreValuation Measures
Market Cap
4.86B
Enterprise Value
5.37B
Trailing P/E
29.90
Forward P/E
18.73
PEG Ratio (5yr expected)
1.21
Price/Sales (ttm)
2.98
Price/Book (mrq)
2.10
Enterprise Value/Revenue
3.30
Enterprise Value/EBITDA
14.16
Financial Highlights
Profitability and Income Statement
Profit Margin
9.98%
Return on Assets (ttm)
3.69%
Return on Equity (ttm)
7.03%
Revenue (ttm)
1.63B
Net Income Avi to Common (ttm)
162.7M
Diluted EPS (ttm)
1.16
Balance Sheet and Cash Flow
Total Cash (mrq)
209.3M
Total Debt/Equity (mrq)
30.70%
Levered Free Cash Flow (ttm)
93.61M